In addition, ETV4 transcriptionally controls the key replisome genes MCM2, ‐4, ‐5, ‐10, and ORC1 expression and affects tumor growth and prognosis of NSCLC patients. This evidence concerns the gene ETV4 and non-small cell lung carcinoma.